ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

An Activatable Nano-Prodrug for Treating Tyrosine-Kinase-Inhibitor-Resistant Non-Small Cell Lung Cancer and for Optoacoustic and Fluorescent Imaging

Xie, Xin; Zhan, Chenyue; Wang, Jie; Zeng, Fang*; Wu, Shuizhu*
Small2020-9DOI: 10.1002/smll.202003451
22被引9阅读
引用收藏
分享

摘要

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and the cause of high rate of mortality. The epidermal growth factor receptor (EGFR)-targeted tyrosine kinase inhibitors are used to treat NSCLC, yet their curative effects are usually compromised by drug resistance. This study demonstrates a nanodrug for treating tyrosine-kinase-inhibitor-resistant NSCLC through inhibiting upstream and downstream EGFR signaling pathways. The main molecule of the nanodrug is synthesized by linking a tyrosine kinase inhibitor gefitinib and a near-infrared dye (NIR) on each side of a disulfide via carbonate bonds, and the nanodrug is then obtained through nanoparticle formation of the main molecule in aqueous medium and concomitant encapsulation of a serine threonine protein kinase (Akt) inhibitor celastrol. Upon administration, the nanodrug accumulates at the tumor region of NSCLC-bearing mice and releases the drugs for tumor inhibition, and the dye for fluorescence and optoacoustic imaging. Through suppressing the phosphorylation of upstream EGFR and downstream Akt in the EGFR pathway by gefitinib and celastrol, respectively, the nanodrug exhibits high inhibition efficacy against orthotopic NSCLC in mouse models.

学科与关键词

关键词
celastrolfluorescent imaginggefitinibnano-prodrugsnon-small cell lung canceroptoacoustic imaging
相关
加载中…
  • Aptamer-Functionalized ZIF-8 Nanomedicine for Targeted Delivery of Gefitinib and siRNA to Treat Tyrosine-Kinase-Inhibitor-Resistant Nonsmall-Cell Lung Cancer
    Liu, Meng; Sun, Chuanchuan; Jiang, Jiangle; Wan, Li; Hu, Chong; Wen, Chunping; Huang, Guiju; Ruan, Qiufen; Wu, Shuang; Qiao, Dan; Zheng, Pengwu; Pan, Qingshan*; Zhu, Wufu*ACS Applied Nano Materials, 2023, 6(23): 21587-21602.
  • A homologous and molecular dual-targeted biomimetic nanocarrier for EGFR-related non-small cell lung cancer therapy
    Xu, Bin; Zeng, Fanjun; Deng, Jialong; Yao, Lintong; Liu, Shengbo; Hou, Hengliang; Huang, Yucheng; Zhu, Hongyuan; Wu, Shaowei; Li, Qiaxuan; Zhan, Weijie; Qiu, Hongrui; Wang, Huili; Li, Yundong; Yang, Xianzhu; Cao, Ziyang*; Zhang, Yu*; Zhou, Haiyu*Bioactive Materials, 2023, 27: 337-347.被引 5
  • Delivery of ATRA and Gefitinib by Polyphenylalanine Nanosystem to Overcome EGFR-TKI Resistance in Lung Adenocarcinoma
    Liu, S.; Zhou, H.; Xu, B.; Deng, J.; Zeng, F.; Qiu, H.
查看全部 →

发表信息

论文状态
公开发表
期刊
Small
发表日期
2020-09
卷期
第 16 卷, 第 38 期
页码
2003451
DOI
10.1002/smll.202003451
语言
ENGLISH
期刊收录
NSL.SCIE
期刊等级
2区
成果收录
SCIE
资助标注
NSFC [21788102, 21875069, 51673066]; Natural Science Foundation of Guangdong Province [2016A030312002]; Fund of Guangdong Provincial Key Laboratory of Luminescence from Molecular Aggregates [2019B030301003]

作者

  • X

    Xie, Xin (第一作者)

  • Z

    Zhan, Chenyue

查看全部 5 位作者收起作者
  • W

    Wang, Jie

  • Z

    Zeng, Fang (通讯)

  • W

    Wu, Shuizhu (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417